| Application no. and date | 03777667.1 (espacenet) (Federated) (European Patent Register), 20031015 | | Patent/reg. no. and date | DK/EP 1562972, 20100908 | | Publication date | 20050817 | | Priority no. and date | US 418972 P, 20021015, US 462014 P, 20030410, US 475762 P, 20030603, US 499048 P, 20030829 | | EP pub. no. and date |
EP 1562972 20050817 | | Effective date | | | Applicant/owner | AbbVie Biotherapeutics Inc., 1500 Seaport Boulevard
Redwood City, CA 94063, US | | Applicant ref. no. | P18564DKEP | | Inventor | TSURUSHITA, Naoya, 3719 Redwood Circle
Palo Alto, CA 94306, US,
VASQUEZ, Maximiliano, 3813 Louis Road
Palo Alto, CA 94303, US,
HINTON, Paul, R., 321 Dunsmuir Terrace 4
Sunnyvale, CA 94085, US,
TSO, Yun, J., 445 Oak Grove Avenue, 16
Menlo Park, CA 94025, US | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C, DK | | Opponent | | | IPC Class | C07K 16/00 (2006.01) , C07K 16/28 (2006.01) | | Title | Modifikation af FcRn-bindingsaffiniteter eller serumhalveringstider for antistoffer ved mutagenese | | Int. application no. | US2003033037 | | Int. publication no. | WO2004035752 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
